My optimism for this stock has just about been overshadowed by a daunting misgiving that I probably should of acted on ages ago.
Is the science as good as it is proclaimed? Is the novel method of delivery truly viable?
If the answers to these two questions is yes then why out of all the so called suitors for our tech are we having so much trouble sealing deals?
I truly started to wonder of the scientific literacy of some of our board members after the initial Bodyguard trials and some of the enthusiastic claims made by our CSO based on little more than that, enthusiasm. Subsequent trials re: Bodyguard have not proven anything either. P&G had first dibs at this and said no thanks. Other companies have shown some interest but still have not committed. Sounds very familiar.
More PT Barnum than Nicolai Tesla.
Of all the potential offerings with ground breaking technology OBJ have had what has been picked up? A bloody wand and some derivitives of it to enhance the application of makeup. Try and tell that to a potential investor.
And what of the needle patch? Did I hear rightly that this could be reconfigured into a hot cold pack?
Don't even want to know why we would even contemplate ultrasound tech. when the paradigm shifting stuff that's been worked on cant seem to find a market.
Where's the turn key packages we were asked to help stump up for in the last capital raising?
Seems to me we paid for an otiose bunch to play scientist/inventor/board of directors.
Hopefully some questions regarding some of these issues will be asked at the AGM.
OBJ Price at posting:
3.3¢ Sentiment: Hold Disclosure: Held
(20min delay)